AUM$8.06B
Expense Ratio0.35%
NAV$127.46
Holdings151
InceptionJan 31, 2006
Price Chart
Key Statistics
Previous Close
$126.38Day Range
$121.81$124.85
52-Week Range
$69.80$131.57
Avg Volume
10.1MDividend Yield
0.35%Expense Ratio
0.35%AUM
$8.06BShares Outstanding
51.8MSector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 94.91% |
| United Kingdom | 1.84% |
| Ireland | 1.41% |
| Switzerland | 1.25% |
| Netherlands | 0.38% |
| Other | 0.20% |
Fund Information
- Issuer
- SPDR
- Category
- Healthcare
- Subcategory
- Biotech
- Inception Date
- Jan 31, 2006
- Exchange
- NYSE_ARCA
- Description
- The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing
Similar ETFs
The State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund issued by SPDR that launched on Jan 31, 2006. It currently manages $8.06B in assets under management. The fund charges an expense ratio of 0.35%. The fund holds 151 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 16.2% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | MRNA | MODERNA INC | 2.31% | 3,436,751 | $181.2M |
| 2 | ROIV | ROIVANT SCIENCES LTD | 1.79% | 4,929,626 | $140.4M |
| 3 | ACLX | ARCELLX INC | 1.67% | 1,192,274 | $130.8M |
| 4 | PCVX | VAXCYTE INC | 1.64% | 2,294,154 | $128.1M |
| 5 | RVMD | REVOLUTION MEDICINES INC | 1.55% | 1,281,179 | $121.5M |
| 6 | GILD | GILEAD SCIENCES INC | 1.50% | 822,320 | $117.1M |
| 7 | FOLD | AMICUS THERAPEUTICS INC | 1.49% | 8,457,519 | $116.5M |
| 8 | AMGN | AMGEN INC | 1.45% | 316,397 | $113.9M |
| 9 | PRAX | PRAXIS PRECISION MEDICINES I | 1.45% | 381,467 | $113.4M |
| 10 | CELC | CELCUITY INC | 1.40% | 979,895 | $110.0M |
| 11 | CGON | CG ONCOLOGY INC | 1.40% | 1,819,053 | $109.5M |
| 12 | MIRM | MIRUM PHARMACEUTICALS INC | 1.39% | 1,251,179 | $109.1M |
| 13 | BMRN | BIOMARIN PHARMACEUTICAL INC | 1.38% | 1,858,184 | $108.5M |
| 14 | VRTX | VERTEX PHARMACEUTICALS INC | 1.37% | 224,424 | $107.4M |
| 15 | UTHR | UNITED THERAPEUTICS CORP | 1.35% | 205,810 | $105.7M |
Page 1 of 4
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | -2.63% | — | ||
| 1W | -0.03% | — | ||
| 1M | +0.83% | — | ||
| 3M | +2.64% | — | ||
| 6M | +35.27% | — | ||
| YTD | +5.19% | — | ||
| 1Y | +45.01% | — | ||
| 3Y | +59.91% | — | ||
| 5Y | -14.73% | — |
Moving Averages
20-Day MA
$125.67
Below 20-Day MA50-Day MA
$125.42
Below 50-Day MA200-Day MA
$104.69
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$131.57
Current Price
$123.10
52-Week Low
$69.80
$69.80$131.57
Current Yield
0.35%
Annual Dividend
$0.4458
Frequency
4x/year
Last Ex-Date
Dec 22, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $0.4066 | Dec 24, 2025 |
| Sep 22, 2025 | $0.0267 | Sep 24, 2025 |
| Jun 23, 2025 | $0.0073 | Jun 25, 2025 |
| Mar 24, 2025 | $0.0053 | Mar 26, 2025 |
| Dec 23, 2024 | $0.0027 | Dec 26, 2024 |
| Sep 23, 2024 | $0.0152 | Sep 25, 2024 |
| Jun 24, 2024 | $0.1148 | Jun 26, 2024 |
| Dec 18, 2023 | $0.0139 | Dec 21, 2023 |
| Jun 20, 2023 | $0.0026 | Jun 23, 2023 |
| Mar 22, 2021 | $0.0400 | Mar 25, 2021 |
| Dec 21, 2020 | $0.1760 | Dec 24, 2020 |
| Sep 21, 2020 | $0.0890 | Sep 24, 2020 |
| Jun 22, 2020 | $0.0168 | Jun 25, 2020 |
| Dec 20, 2019 | $0.0009 | Dec 26, 2019 |
| Sep 20, 2019 | $0.0032 | Sep 25, 2019 |
| Dec 21, 2018 | $0.0120 | Dec 27, 2018 |
| Sep 21, 2018 | $0.0726 | Sep 26, 2018 |
| Jun 15, 2018 | $0.0585 | Jun 20, 2018 |
| Mar 16, 2018 | $0.0591 | Mar 21, 2018 |
| Dec 15, 2017 | $0.0347 | Dec 26, 2017 |
Dividend Payments Over Time
Category Comparison
| Metric | XBI | Healthcare(223 ETFs) | Biotech(39 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.35% | 0.60% | 0.84% |
| AUM | $8.06B | $1.25B | $1.62B |
| Dividend Yield | 0.35% | 2.75% | 14.38% |
| Avg Volume | 10.1M | 769.9K | 1.3M |
| Holdings | 151 | 182 | 67 |
| Performance | |||
| 1-Month Return | +0.21% | -3.02% | -2.05% |
| 6-Month Return | +33.06% | +5.85% | +15.05% |
| YTD Return | +3.65% | +0.17% | +1.05% |
| 1-Year Return | +46.54% | +16.65% | +24.43% |
Compare with Another ETF
Search for an ETF to compare with XBI: